Budesonide/formoterol fumarate dihydrate <i>versus</i> budesonide with a novel suspension technology for uncontrolled asthma: phase 3 LITHOS study

Alberto Papi, Robert A. Wise, David J. Jackson, Njira Lugogo, Ruchong Chen, Hassan Chami, Clara Armengol, Sami Z. Daoud, Emma Nauclér, Karin Bowen, Ayman Megally, Olami Sobande, Mehul Patel

Open source

DOI: 10.1183/23120541.01818-2025
Published: 2026-08-06
Container: ERJ Open Research
Publisher: European Respiratory Society (ERS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1183/23120541.01818-2025,
  title = {Budesonide/formoterol fumarate dihydrate
                    <i>versus</i>
                    budesonide with a novel suspension technology for uncontrolled asthma: phase 3 LITHOS study},
  author = {Alberto Papi and Robert A. Wise and David J. Jackson and Njira Lugogo and Ruchong Chen and Hassan Chami and Clara Armengol and Sami Z. Daoud and Emma Nauclér and Karin Bowen and Ayman Megally and Olami Sobande and Mehul Patel},
  year = {2026},
  journal = {ERJ Open Research},
  doi = {10.1183/23120541.01818-2025},
  url = {https://doi.org/10.1183/23120541.01818-2025}
}

RIS

TY  - JOUR
TI  - Budesonide/formoterol fumarate dihydrate
                    <i>versus</i>
                    budesonide with a novel suspension technology for uncontrolled asthma: phase 3 LITHOS study
AU  - Alberto Papi
AU  - Robert A. Wise
AU  - David J. Jackson
AU  - Njira Lugogo
AU  - Ruchong Chen
AU  - Hassan Chami
AU  - Clara Armengol
AU  - Sami Z. Daoud
AU  - Emma Nauclér
AU  - Karin Bowen
AU  - Ayman Megally
AU  - Olami Sobande
AU  - Mehul Patel
PY  - 2026
JO  - ERJ Open Research
DO  - 10.1183/23120541.01818-2025
UR  - https://doi.org/10.1183/23120541.01818-2025
ER  -

APA

Papi, A., Wise, R. A., Jackson, D. J., Lugogo, N., Chen, R., Chami, H., Armengol, C., Daoud, S. Z., Nauclér, E., Bowen, K., Megally, A., Sobande, O., & Patel, M. (2026). Budesonide/formoterol fumarate dihydrate <i>versus</i> budesonide with a novel suspension technology for uncontrolled asthma: phase 3 LITHOS study. ERJ Open Research. https://doi.org/10.1183/23120541.01818-2025

Source records

crossref · retrieved 2026-11-10T13:38:04.257Z